$SAN News Article - Sanofi US enters into co-promotion agreement with Provention Bio, Inc. to launch teplizumab, an investigational disease-modifying therapy for type 1 diabetes https://marketwirenews.com/news-releases/sano...73177.html
(0)
(0)
Banco Santander S.A. ADS (SAN) Stock Research Links